These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34970551)

  • 1. Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.
    Chang WL; Lee WR; Kuo YC; Huang YH
    Front Cell Dev Biol; 2021; 9():797026. PubMed ID: 34970551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics.
    Shah F; Patel S; Begum R; Dwivedi M
    Autoimmun Rev; 2021 Aug; 20(8):102868. PubMed ID: 34118458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3.
    Boniface K; Jacquemin C; Darrigade AS; Dessarthe B; Martins C; Boukhedouni N; Vernisse C; Grasseau A; Thiolat D; Rambert J; Lucchese F; Bertolotti A; Ezzedine K; Taieb A; Seneschal J
    J Invest Dermatol; 2018 Feb; 138(2):355-364. PubMed ID: 28927891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo: A focus on pathogenesis and its therapeutic implications.
    Bergqvist C; Ezzedine K
    J Dermatol; 2021 Mar; 48(3):252-270. PubMed ID: 33404102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
    Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells.
    Boniface K; Seneschal J
    Exp Dermatol; 2019 Jun; 28(6):656-661. PubMed ID: 30636075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.
    Wang Y; Li S; Li C
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):299-323. PubMed ID: 34283349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insight into the role of exosomes in vitiligo.
    Wong PM; Yang L; Yang L; Wu H; Li W; Ma X; Katayama I; Zhang H
    Autoimmun Rev; 2020 Nov; 19(11):102664. PubMed ID: 32942029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of melanocyte death in vitiligo.
    Chen J; Li S; Li C
    Med Res Rev; 2021 Mar; 41(2):1138-1166. PubMed ID: 33200838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma.
    Byrne KT; Côté AL; Zhang P; Steinberg SM; Guo Y; Allie R; Zhang W; Ernstoff MS; Usherwood EJ; Turk MJ
    J Clin Invest; 2011 May; 121(5):1797-809. PubMed ID: 21540555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem Cell Therapy Offers a Possible Safe and Promising Alternative Approach for Treating Vitiligo: A Review.
    Esquivel D; Mishra R; Srivastava A
    Curr Pharm Des; 2020; 26(37):4815-4821. PubMed ID: 32744962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature.
    Relke N; Gooderham M
    J Cutan Med Surg; 2019; 23(3):298-306. PubMed ID: 30902022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo, From Physiopathology to Emerging Treatments: A Review.
    Migayron L; Boniface K; Seneschal J
    Dermatol Ther (Heidelb); 2020 Dec; 10(6):1185-1198. PubMed ID: 32949337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of pediatric cutaneous autoimmunity: The sister diseases vitiligo and alopecia areata.
    Silverberg N
    Clin Dermatol; 2022; 40(4):363-373. PubMed ID: 35183681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Networks of CD8
    Fukuda K
    Front Immunol; 2022; 13():866703. PubMed ID: 35432377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines: the yin and yang of vitiligo pathogenesis.
    Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
    Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling.
    Martins C; Migayron L; Drullion C; Jacquemin C; Lucchese F; Rambert J; Merhi R; Michon P; Taieb A; Rezvani HR; de Rinaldis E; Seneschal J; Boniface K
    J Invest Dermatol; 2022 Apr; 142(4):1194-1205.e7. PubMed ID: 34655610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Memory CD8
    Riding RL; Harris JE
    J Immunol; 2019 Jul; 203(1):11-19. PubMed ID: 31209143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.